Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer
Crossref DOI link: https://doi.org/10.1186/bcr3661
Published Online: 2014-05-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Perez, Edith A
Hurvitz, Sara A
Amler, Lukas C
Mundt, Kirsten E
Ng, Vivian
Guardino, Ellie
Gianni, Luca
Text and Data Mining valid from 2014-05-23
Version of Record valid from 2014-05-23
Article History
Received: 4 September 2013
Accepted: 7 April 2014
First Online: 23 May 2014